Volume 14, Number 3—March 2008
Research
Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City
Ethan E. Bodle*, Jennifer A. Cunningham*, Phyllis Della-Latta*, Neil W. Schluger*, and Lisa Saiman*
Table 1
HIV-negative patients with positive nontuberculous mycobacteria cultures and disease, New York–Presbyterian Hospital, Columbia University Medical Center, New York, New York, 2000–2003
| NTM species* | No. positive cultures | Adequate data to assess case status† | No. patients with disease (%)‡ |
|---|---|---|---|
| All species | 505 | 375 | 119 (32) |
| Mycobacterium avium (MAC) complex | 422 | 297 | 79 (27) |
| Rapidly growing mycobacteria‡ | 45 | 41 | 25 (61) |
| M. abscessus | 14 | 13 | 11 (85) |
| M. chelonae | 15 | 13 | 4 (31) |
| M. fortuitum | 16 | 15 | 10 (67) |
| M. gordonae | 25 | 6 | 0 |
| M. kansasii ‡ | 12 | 10 | 7 (70) |
| M. marinum ‡ | 4 | 4 | 4 (100) |
| M. scrofulaceum | 5 | 4 | 0 |
| M. xenopi | 13 | 9 | 5 (56) |
*M. flavescens, M. gastri, M. haemophilum, and M. neoaurum were isolated once each.
†Patients with adequate clinical, radiographic, and mycobacteriologic data to assess case status.
‡Greater proportion of rapidly growing mycobacteria, M. kansasii, and M. marinum caused nontuberculous mycobacteria (NTM) disease when compared with MAC (p<0.01).
Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.